TABLE II. Demographic and laboratory data of the HBV-DNA positive kidney transplant recipients.
| Patients | ||
|---|---|---|
| 1 | 2 | |
| Gender | Male | Female |
| Age (years) | 45 | 39 |
| Type of dialysis | Haemodialysis | Haemodialysis |
| Time on dialysis (months) | 4 | 15 |
| Time after transplant (years) | 9 | 6 |
| Donor | Living | Cadaver |
| Transfusion | None | None |
| Drug injection use | None | None |
| HBV vaccination | Not sure | Yes |
| Immunosuppression | Prednisone/sirolimus/MMF | Prednisone/sirolimus/MMF |
| Primary disease | Hypertensive nephropathy | Diabetic nephropathy |
| HBV serology pre transplant | ||
| Anti-HBs | Negative | Negative |
| Anti-HBc | Negative | Negative |
| HBV serology pos transplant | ||
| Anti-HBs | Negative | Negative |
| Anti-HBc | Negative | Negative |
| Anti-HCV | Negative | Negative |
| ALT | Normal | Normal |
| GGT | Normal | Normal |
| HBV-DNA (UI/mL) | 3.5 | 3.1 |
ALT: alanine aminotransferase; GGT: gama-glutamyl transpeptidase; anti-HBc: hepatitis B core antibodies; anti-HBs: hepatitis B surface antibodies; HBV: hepatitis B virus; HCV: hepatitis C virus; MMF: mycophenolate mofetil.